Over the past three years, the region has witnessed remarkable advancements in diagnostics, therapeutics, vaccines, and health technologies, driven by shared commitments to innovate and collaborate. As we move further away from COVID-19, however, the urgency to accelerate this momentum across APAC has begun to wane. At the same time, global economic uncertainty has taken its toll on the biomedical and healthtech sectors, with many companies operating in an environment with limited access to capital. In this private roundtable, experts will explore how to sustain and maintain the gains of the last three years, the expanding role of patients in the ecosystem, and how emerging tools and technologies are being leveraged to accelerate progress. 

Moderator

Sung Hee Choe

Senior Director, FasterCures, Milken Institute

Speakers

Swee Kheng Khor

CEO, Angsana Health

Susana Beatriz Latay

Chief Operating Officer, KonsultaMD; Vice President, Ayala Healthcare Holdings, Inc.

John C.W. Lim

Chairman, Consortium for Clinical Research and Innovation, Singapore

Eric Wong

Group Chief Data and Strategy Officer, Data and Strategy Office, National Healthcare Group